Cargando…

2366. PCR Followed by Toxin EIA for the Diagnosis of C. difficile Infection

BACKGROUND: In June 2017 for the diagnosis of Clostridioides difficile infection (CDI), Renown Health transitioned from utilizing polymerase chain reaction (PCR) to a two-step algorithm of PCR followed by toxin enzyme immunoassay (EIA) if PCR was positive. Providers were encouraged to forgo treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yu, Mohadjer, Kiya, McCombs, Amy, Thompson, Jessica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809906/ http://dx.doi.org/10.1093/ofid/ofz360.2044

Ejemplares similares

781. C.difficile PCR+/ Toxin EIA- treat or not treat? A clinician survey
por: Nath, Sarath G, et al.
Publicado: (2020)

677. To Treat or Not To Treat: Patients with Clostridioides difficile PCR-positive/Toxin EIA negative Test Results
por: Yang, Krista, et al.
Publicado: (2023)

Clinical Characteristics and Outcomes of Hematologic Malignancy Patients with Clostridium difficile Toxin EIA vs. PCR Positive Test Results
por: Ziegler, Matthew, et al.
Publicado: (2017)

Toxin Detection by Cell Culture Neutralization Assay [CYT] and Toxin based EIA [Tox EIA] among Recurrent Episodes of CDI Diagnosed by PCR
por: Kamboj, Mini, et al.
Publicado: (2017)

Clinical Correlation of a Clostridium difficile Testing Algorithm Reflexing PCR Positive Specimens to Toxin Enzyme Immunoassay (EIA)
por: Rios, Maria Bueno, et al.
Publicado: (2017)

Can a toxin gene NAAT be used to predict toxin EIA and the severity of Clostridium difficile infection?
por: Garvey, Mark I., et al.
Publicado: (2017)

750. Retrospective Evaluation of the Three-Step EIA/PCR Algorithm as a Cost-Effective Method for Detection and Treatment of Clostridium Difficile Infection
por: Kulla, Bakri, et al.
Publicado: (2021)

325. Empiric Antibiotics for COVID-19 and the Utility of Procalcitonin
por: Desens, Adrienne D, et al.
Publicado: (2021)

2366. Treatment Characteristics and Predictors of Mortality in Patients With Infected Chronic Pressure Ulcers in Detroit
por: Veve, Michael P, et al.
Publicado: (2018)

2366. Impact of the Febrile Podcast and Learning Resource as an Infectious Diseases Education Platform
por: Dong, Sara W, et al.
Publicado: (2022)

609. Development of an Aspergillus Antigen Detection EIA
por: Bridges, Nicole, et al.
Publicado: (2023)

839. Effect of Clostridioides difficile (C. difficile) Toxin Test Reporting on Clinical Treatment and Outcomes of Toxin-Negative PCR-Positive Patients at Five California Hospitals
por: Polage, Christopher R, et al.
Publicado: (2019)

1092. Tuning Down Clostridioides difficile PCR Sensitivity Reduces Treatment for C. difficile Infection in Toxin-Negative Patients With No Increase in Adverse Outcomes
por: Hitchcock, Matthew, et al.
Publicado: (2018)

PROJECT ADMINISTATION AGREEMENT KN2366/DG
por: THE EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH, CERN, et al.
Publicado: (2014)

2366. Profile and Outcomes of Vaccinated Adult Individuals with COVID-19 Breakthrough Infections Hospitalized in a Tertiary Hospital in the Philippines
por: Llanes, Mark Ramon Victor B, et al.
Publicado: (2023)

Enzyme Immunoassay for C. difficile Toxin Reduces Lab ID Events but Fails to Detect Clinically Significant C. difficile Infection
por: Ridgway, Jessica P, et al.
Publicado: (2017)

Epidemiology and virulence-associated genes of Clostridioides difficile isolates and factors associated with toxin EIA results at a university hospital in Japan
por: Okada, Yuta, et al.
Publicado: (2019)

386. Clostridioides difficile PCR Cycle Threshold to Determine Toxin Positivity Status
por: Crone, Andrew S, et al.
Publicado: (2022)

Differences in Clinical Characteristics and Outcomes of Patients with Community-Onset Clostridium difficile Infection who Tested Positive by EIA Compared with NAAT through a Two-Step Algorithm
por: Phipps, Erin C, et al.
Publicado: (2017)

PReS-FINAL-2366: Paediatric rheumatology in South Africa
por: Scott, C
Publicado: (2013)

PCR Cycle-Threshold-Derived Toxin Identifies Patients at Low-Risk for Complications of C. difficile Infection Who Do Not Require Treatment
por: Hitchcock, Matthew, et al.
Publicado: (2017)

2379. It’s Getting Complicated: Outcomes of Clostridiodes difficile PCR Positive/Toxin-Negative Patients
por: Morillas, Jose A, et al.
Publicado: (2019)

RF-induced heating of interventional devices at 23.66 MHz
por: Özen, Ali Caglar, et al.
Publicado: (2023)

Endogenous Serum IgG Antibodies to Clostridium difficile Toxin B Are Associated with Protection against C. difficile Infection Recurrence
por: Kelly, Ciaran P, et al.
Publicado: (2017)

1094. Performance of Toxin Enzyme Immunoassays and PCR Cycle Threshold for Differentiating Clostridium difficile Infection From Colonization in Children With Diarrhea
por: Balaji, Aakash, et al.
Publicado: (2018)

135. Impact of Clostridioides difficile Toxin Confirmation on Subsequent C. difficile Treatment in a Rural Health System (IT-CDI)
por: Crawford, Jacquelyn, et al.
Publicado: (2023)

2366 Urinary tract infections in children with kidney allografts: Risk factors and clinical consequences
por: Farrell, Annie, et al.
Publicado: (2018)

671. Introduction of simultaneous Clostridioides difficile Antigen and Toxin A and B detection for diagnosis of C. difficile related diarrhea at Michael E. DeBakey VA Medical Center
por: Ashley, Patrycja, et al.
Publicado: (2023)

Abstract papers from the Energy Informatics.Academy Conference 2022 (EI.A 2022)
Publicado: (2022)

627. Differences in C. difficile Toxin A Binding in Humans: Adults vs. Infants
por: Goldman, David, et al.
Publicado: (2018)

1494. Clinical Factors Associated with a Positive C. difficile PCR Test
por: Cushman, Teresa, et al.
Publicado: (2019)

2351. Rate and Consequences of Missed Clostridioides (Clostridium) difficile Infection Diagnosis from Non-disclosure of Clostridioides difficile Multiplex PCR Results. Two-Hospital Experience
por: Zacharioudakis, Ioannis, et al.
Publicado: (2019)

2398. Effect of Eosinopenia and Binary Toxin on Clostridioides difficile Infection Clinical Outcomes
por: Carlson, Travis J, et al.
Publicado: (2019)

Environmental impact assessment (EIA) : cutting edge for the twenty-first century
por: Gilpin, Alan
Publicado: (1995)

EIA effectiveness in Vietnam: key stakeholder perceptions
por: Clarke, B.D., et al.
Publicado: (2021)

CD4+ T Cells Specific for C. difficile Toxins are a Marker of Patients with Active Relapsing Disease
por: Cook, Laura, et al.
Publicado: (2017)

526. An EMR-Based Diagnostic Stewardship Intervention for GI mPCR Aimed at Reducing Inappropriate C. difficile Tests
por: Newman, Margaret E, et al.
Publicado: (2018)

507. Degree of Concordance of Clostridium difficile Strains in Adults with Community-Associated C. difficile Infection and Infants With C. difficile Colonization
por: Clayton, Jason A, et al.
Publicado: (2018)

2364. Surprising Prescribing: Treatment Practices following Addition of Toxin Testing to an Existing Molecular Test for Clostridioides difficile
por: Miller, Ryan, et al.
Publicado: (2019)

2435. The Impact of Treatment Strategy and Toxin Status on Outcomes of Patients with Clostridioides difficile Infections
por: Friedman, Daniel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nstdjrgoeq3eramh8f2f2ue4v1